Cargando…

Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review

INTRODUCTION: All major international guidelines for the management of infective endocarditis (IE) have undergone major revisions, recommending antibiotic prophylaxis (AP) restriction to high-risk patients or foregoing AP completely. We performed a systematic review to investigate the effect of thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Michael L., Doyle, Mathew P., McNamara, Nicholas, Tardo, Daniel, Mathew, Manish, Robinson, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020745/
https://www.ncbi.nlm.nih.gov/pubmed/33784909
http://dx.doi.org/10.1177/17539447211002687
_version_ 1783674624153747456
author Williams, Michael L.
Doyle, Mathew P.
McNamara, Nicholas
Tardo, Daniel
Mathew, Manish
Robinson, Benjamin
author_facet Williams, Michael L.
Doyle, Mathew P.
McNamara, Nicholas
Tardo, Daniel
Mathew, Manish
Robinson, Benjamin
author_sort Williams, Michael L.
collection PubMed
description INTRODUCTION: All major international guidelines for the management of infective endocarditis (IE) have undergone major revisions, recommending antibiotic prophylaxis (AP) restriction to high-risk patients or foregoing AP completely. We performed a systematic review to investigate the effect of these guideline changes on the global incidence of IE. METHODS: Electronic database searches were performed using Ovid Medline, EMBASE and Web of Science. Studies were included if they compared the incidence of IE prior to and following any change in international guideline recommendations. Relevant studies fulfilling the predefined search criteria were categorized according to their inclusion of either adult or pediatric patients. Incidence of IE, causative microorganisms and AP prescription rates were compared following international guideline updates. RESULTS: Sixteen studies were included, reporting over 1.3 million cases of IE. The crude incidence of IE following guideline updates has increased globally. Adjusted incidence increased in one study after European guideline updates, while North American rates did not increase. Cases of IE with a causative pathogen identified ranged from 62% to 91%. Rates of streptococcal IE varied across adult and pediatric populations, while the relative proportion of staphylococcal IE increased (range pre-guidelines 16–24.8%, range post-guidelines 26–43%). AP prescription trends were reduced in both moderate and high-risk patients following guideline updates. DISCUSSION: The restriction of AP to only high-risk patients has not resulted in an increase in the incidence of streptococcal IE in North American populations. The evidence of the impact of AP restriction on IE incidence is still unclear for other populations. Future population-based studies with adjusted incidence of IE, AP prescription rates and accurate pathogen identification are required to delineate findings further in these other regions.
format Online
Article
Text
id pubmed-8020745
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-80207452021-04-16 Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review Williams, Michael L. Doyle, Mathew P. McNamara, Nicholas Tardo, Daniel Mathew, Manish Robinson, Benjamin Ther Adv Cardiovasc Dis Review INTRODUCTION: All major international guidelines for the management of infective endocarditis (IE) have undergone major revisions, recommending antibiotic prophylaxis (AP) restriction to high-risk patients or foregoing AP completely. We performed a systematic review to investigate the effect of these guideline changes on the global incidence of IE. METHODS: Electronic database searches were performed using Ovid Medline, EMBASE and Web of Science. Studies were included if they compared the incidence of IE prior to and following any change in international guideline recommendations. Relevant studies fulfilling the predefined search criteria were categorized according to their inclusion of either adult or pediatric patients. Incidence of IE, causative microorganisms and AP prescription rates were compared following international guideline updates. RESULTS: Sixteen studies were included, reporting over 1.3 million cases of IE. The crude incidence of IE following guideline updates has increased globally. Adjusted incidence increased in one study after European guideline updates, while North American rates did not increase. Cases of IE with a causative pathogen identified ranged from 62% to 91%. Rates of streptococcal IE varied across adult and pediatric populations, while the relative proportion of staphylococcal IE increased (range pre-guidelines 16–24.8%, range post-guidelines 26–43%). AP prescription trends were reduced in both moderate and high-risk patients following guideline updates. DISCUSSION: The restriction of AP to only high-risk patients has not resulted in an increase in the incidence of streptococcal IE in North American populations. The evidence of the impact of AP restriction on IE incidence is still unclear for other populations. Future population-based studies with adjusted incidence of IE, AP prescription rates and accurate pathogen identification are required to delineate findings further in these other regions. SAGE Publications 2021-03-30 /pmc/articles/PMC8020745/ /pubmed/33784909 http://dx.doi.org/10.1177/17539447211002687 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review
Williams, Michael L.
Doyle, Mathew P.
McNamara, Nicholas
Tardo, Daniel
Mathew, Manish
Robinson, Benjamin
Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review
title Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review
title_full Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review
title_fullStr Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review
title_full_unstemmed Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review
title_short Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review
title_sort epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020745/
https://www.ncbi.nlm.nih.gov/pubmed/33784909
http://dx.doi.org/10.1177/17539447211002687
work_keys_str_mv AT williamsmichaell epidemiologyofinfectiveendocarditisbeforeversusafterchangeofinternationalguidelinesasystematicreview
AT doylemathewp epidemiologyofinfectiveendocarditisbeforeversusafterchangeofinternationalguidelinesasystematicreview
AT mcnamaranicholas epidemiologyofinfectiveendocarditisbeforeversusafterchangeofinternationalguidelinesasystematicreview
AT tardodaniel epidemiologyofinfectiveendocarditisbeforeversusafterchangeofinternationalguidelinesasystematicreview
AT mathewmanish epidemiologyofinfectiveendocarditisbeforeversusafterchangeofinternationalguidelinesasystematicreview
AT robinsonbenjamin epidemiologyofinfectiveendocarditisbeforeversusafterchangeofinternationalguidelinesasystematicreview